This website uses cookies to ensure you get the best experience on our website. By carrying on browsing, you are giving your consent for us to set cookies.

Learn more
Ok, I agree
Thanks for your contribution! You will receive your copy of the summary report in early March 2020.
Full name
Company
Position
Corporate email
What is your role in the company?
In which countries do you have expertise in market access?
1. What are, in your opinion, the most important developments in the field of market access in 2020? Please, provide a response by country
2. Were there any changes in 2020 in relation to the stakeholder landscape in the market access field?
3. Were there any changes in 2020 in relation to the payment mechanism for medical devices / medical procedures / diagnostic tests?
4. Were there any changes in 2020 in relation to innovation funding?
6. Were there any changes in 2020 in relation to the health technology assessment frameworks?
7. Were there any changes in 2020 in relation to reimbursement of digital technologies?
8. In which countries did market access become more difficult in 2020, why?
9. In which countries did market access become easier in 2020, why?
10. What are, in your opinion, the most important planned / anticipated developments in the field of market access in 2021? Please, provide a response by country
11. Are there any planned / anticipated developments in 2021 in relation to the stakeholder landscape in the market access field?
12. Are there any planned / anticipated developments in 2021 in relation to the payment mechanism for medical devices / medical procedures / diagnostic tests?
13. Are there any planned / anticipated developments in 2021 in relation to innovation funding?
14. Are there any planned / anticipated developments in 2021 in relation to the health technology assessment frameworks?
15. Are there any planned / anticipated developments in 2021 in relation to reimbursement of digital technologies?